Transferrin receptor 2 deficiency promotes macrophage polarization and inflammatory arthritis.


Journal

Redox biology
ISSN: 2213-2317
Titre abrégé: Redox Biol
Pays: Netherlands
ID NLM: 101605639

Informations de publication

Date de publication:
04 2023
Historique:
received: 23 12 2022
revised: 19 01 2023
accepted: 24 01 2023
pubmed: 7 2 2023
medline: 22 2 2023
entrez: 6 2 2023
Statut: ppublish

Résumé

Rheumatoid arthritis is an inflammatory joint disease in which synovial iron deposition has been described. Transferrin receptor 2 (Tfr2) represents a critical regulator of systemic iron levels. Loss of Tfr2 function in humans and mice results in iron overload. As iron contributes to inflammatory processes, we investigated whether Tfr2-deletion affects the pathogenesis of inflammatory arthritis in an iron-dependent manner. Using a global and conditional genetic disruption of Tfr2, we assessed the relevance of Tfr2 in K/BxN serum-transfer arthritis (STA) and macrophage polarization. Male Tfr2 Taken together, these findings suggest a protective role of Tfr2 in macrophages on the progression of arthritis via suppression of M1-like polarization.

Identifiants

pubmed: 36746004
pii: S2213-2317(23)00017-4
doi: 10.1016/j.redox.2023.102616
pmc: PMC9932570
pii:
doi:

Substances chimiques

Iron E1UOL152H7
Receptors, Transferrin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102616

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest LCH received support for clinical trials to his institution from Alexion, Ascendis, Takeda, and UCB. MR received honoraria for lectures from UCB. All other authors have no financial conflicts of interest.

Références

Bone. 2020 Aug;137:115400
pubmed: 32380257
Sci Rep. 2016 Aug 01;6:30725
pubmed: 27477597
Immunity. 2002 Feb;16(2):157-68
pubmed: 11869678
Biochim Biophys Acta. 2006 Jul;1763(7):700-10
pubmed: 16891003
J Immunol. 2001 Aug 1;167(3):1601-8
pubmed: 11466382
BMB Rep. 2019 Jun;52(6):360-372
pubmed: 31186085
Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6674-9
pubmed: 11390994
Med Sci Monit. 2004 Apr;10(4):BR91-5
pubmed: 15039637
Front Immunol. 2016 Jun 02;7:213
pubmed: 27313578
Science. 2004 Dec 17;306(5704):2090-3
pubmed: 15514116
Biochim Biophys Acta Mol Cell Res. 2019 Dec;1866(12):118535
pubmed: 31446062
Front Immunol. 2014 Oct 17;5:514
pubmed: 25368618
Int J Mol Sci. 2015 Nov 02;16(11):26087-124
pubmed: 26540040
Am J Physiol Gastrointest Liver Physiol. 2016 Feb 1;310(3):G171-80
pubmed: 26608187
Biochem J. 1948;42(4):577-81
pubmed: 16748331
Ann Rheum Dis. 1983 Feb;42(1):89-93
pubmed: 6830329
Exp Hematol. 1992 Jun;20(5):605-10
pubmed: 1587306
Blood. 2018 Feb 22;131(8):899-910
pubmed: 29237594
Ann N Y Acad Sci. 2002 Jun;966:131-42
pubmed: 12114267
EMBO Rep. 2022 Apr 5;23(4):e53746
pubmed: 35199910
Int J Infect Dis. 2007 Nov;11(6):482-7
pubmed: 17600748
Gut. 2005 Jul;54(7):980-6
pubmed: 15951546
Nat Rev Immunol. 2013 Mar;13(3):159-75
pubmed: 23435331
Cell. 2017 Jan 26;168(3):344-361
pubmed: 28129536
N Engl J Med. 2011 Dec 8;365(23):2205-19
pubmed: 22150039
Blood. 2010 Dec 9;116(24):5357-67
pubmed: 20826723
Semin Hematol. 2021 Jul;58(3):188-200
pubmed: 34389111
Arthritis Rheum. 1973 May-Jun;16(3):298-304
pubmed: 4708010
Nat Rev Rheumatol. 2012 Nov;8(11):656-64
pubmed: 23007741
J Exp Med. 1994 Sep 1;180(3):969-76
pubmed: 7520477
J Am Heart Assoc. 2017 Jan 23;6(1):
pubmed: 28115312
Calcif Tissue Int. 2014 Jun;94(6):632-9
pubmed: 24652331
Nat Metab. 2019 Jan;1(1):111-124
pubmed: 30886999
Ann Rheum Dis. 1992 Apr;51(4):516-21
pubmed: 1586252
Osteoporos Int. 2009 Apr;20(4):549-55
pubmed: 18661088
J Clin Invest. 2008 Nov;118(11):3537-45
pubmed: 18982160
J Leukoc Biol. 2004 Feb;75(2):163-89
pubmed: 14525967
Ann Rheum Dis. 1985 Mar;44(3):183-8
pubmed: 3977421
Osteoporos Int. 2011 Aug;22(8):2313-9
pubmed: 20976594
Blood Adv. 2020 Aug 25;4(16):3853-3863
pubmed: 32810223
Rheumatology (Oxford). 2012 Mar;51(3):451-9
pubmed: 22179732
Mediators Inflamm. 2015;2015:516740
pubmed: 25878400
Nat Genet. 2000 May;25(1):14-5
pubmed: 10802645
Bone Res. 2018 Apr 27;6:15
pubmed: 29736302
Front Pharmacol. 2014 Mar 06;5:34
pubmed: 24639653
Cell Immunol. 1989 Jun;121(1):1-12
pubmed: 2524277
Autoimmun Rev. 2007 Jun;6(6):366-72
pubmed: 17537382
Nat Med. 2009 Mar;15(3):259-66
pubmed: 19252502
Oxid Med Cell Longev. 2019 Dec 14;2019:7536805
pubmed: 31934269
Annu Rev Nutr. 2010 Aug 21;30:105-22
pubmed: 20420524

Auteurs

Maria G Ledesma-Colunga (MG)

Department of Medicine III and Center for Healthy Aging, Technische Universität Dresden, Dresden, Germany.

Ulrike Baschant (U)

Department of Medicine III and Center for Healthy Aging, Technische Universität Dresden, Dresden, Germany.

Heike Weidner (H)

Department of Medicine III and Center for Healthy Aging, Technische Universität Dresden, Dresden, Germany.

Tiago C Alves (TC)

Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany.

Peter Mirtschink (P)

Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany.

Lorenz C Hofbauer (LC)

Department of Medicine III and Center for Healthy Aging, Technische Universität Dresden, Dresden, Germany.

Martina Rauner (M)

Department of Medicine III and Center for Healthy Aging, Technische Universität Dresden, Dresden, Germany. Electronic address: martina.rauner@ukdd.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH